Dr. Zaheer-Ud-Din Babar
My Social Links

Dr. Zaheer-Ud-Din Babar

Professor
University of Huddersfield, UK

Highest Degree
Ph.D. in Pharmacy from Universiti Sains Malaysia, Malaysia

Share this Profile

Biography

Dr. Zaheer-Ud-Din Babar is currently working as Senior Lecturer and Head of Pharmacy Practice, School of Pharmacy, University of Auckland, New Zealand. He obtained his PhD in Pharmacy University Sains Malaysia, Penang, Malaysia in 2006. Dr. Zaheer received number of honors includes, Second Prize for Population Health Category (summer studentship April 2013, University of Auckland, New Zealand), Vice Chancellors Research Excellence Award, and Sanggar Sanjung Award by University Sains Malaysia. His professional experience include Production Pharmacist at P.D.H. Pharmaceuticals (Pvt.) Ltd, Lahore Pakistan, Staff Pharmacist at Aga Khan University Hospital, Karachi, Pakistan, Lecturer and Senior Lecturer at University College Sedaya International (UCSI) Kuala Lumpur Malaysia, Lecturer at University Sains Malaysia (USM), Penang, Malaysia, Lecturer, Senior Lecturer and Examination Director at University of Auckland, New Zealand. He also worked as Visiting Researcher, Department of Population Medicine, Harvard Medical School, Harvard University, Boston MA. He also supervised number of post graduate and undergraduate students. He is serving as Editor-in-Chief of Journal of Pharmaceutical Policy and Practice. He has published (79) articles in journals, (1) book and (5) chapters in books, (12) papers in journals supplements, (31) papers in conferences as author/co-author. He has also received number of grants for his research work. He is professional member of different organizations such as Associate Member of Pharmaceutical Society of New Zealand, International Society for Pharmacoeconomics and Outcome Research, Associate Member of Malaysian Pharmaceutical Society, International Health Economics Association (IHEA), European Society of Clinical Pharmacy, World Association of Medical Editors (WAME), Associate Member Health Action International Asia Pacific. He attended meeting as Resource Person. He also delivered several invited lectures in different universities. He is also serving as reviewer in number of peer review journals. He also participated in number of conferences and seminars.

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Policy
62%
Pharmaceutical Practice
90%
Infectious Diseases
75%
Health Policy
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Zaheer-Ud-Din Babar, A.M. Siraj and L. Curley, 2018. A review of DTCA techniques: Appraising their success and potential impact on medication users. Res. Soc. Administrative Pharm., 14: 218-227.
    CrossRef  |  Direct Link  |  
  2. Grover, P., Zaheer-Ud-Din Babar, R. Oehmen and A. Vitry, 2018. Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study. Health Policy, 122: 243-249.
    CrossRef  |  Direct Link  |  
  3. Zaheer-Ud-Din Babar, T.M. Gammie, D. Gnjidic, E. Reeve and V. Jordan et al., 2017. Withdrawal of antihypertensive drugs in older people. Cochrane Library. 10.1002/14651858.CD012572.
    CrossRef  |  
  4. Vogler, S., V. Paris, A. Ferrario, V.J. Wirtz and K. de Joncheere et al., 2017. How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries. Applied Health Econ. Health Policy, 15: 307-321.
  5. Vogler, S., N. Zimmermann and Zaheer-Ud-Din Babar, 2017. Price comparison of high-cost originator medicines in European countries. Expert Rev. Pharm. Outcomes Res., 17: 221-230.
    CrossRef  |  Direct Link  |  
  6. Scahill, S.L., M. Atif and Z.U. Babar, 2017. Defining pharmacy and its practice: A conceptual model for an international audience. Integrated Pharm. Res. Pract., 6: 121-129.
    CrossRef  |  Direct Link  |  
  7. Sarwar, M.R., M. Atif, S. Scahill, A. Saqib, M. Qamar-uz-Zaman and Z. Babar, 2017. Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan. J. Pharm. Policy Pract., Vol. 10. 10.1186/s40545-017-0112-z.
    CrossRef  |  
  8. Salmasi, S., K.S. Lee, L.C. Ming, C.F. Neoh, M.E. Elrggal, T.M. Khan and M.A. Hadi, 2017. Pricing appraisal of anti-cancer drugs in the South East Asian, Western Pacific and East Mediterranean region. BMC Cancer, Vol. 17. 10.1186/s12885-017-3888-y.
    CrossRef  |  Direct Link  |  
  9. Saleem, A., A. Khan, A. Ahmad, M.U. Khan and Z.U. Babar, 2017. Patient inaccessibility to antifungal drugs in developing nations: The case of Pakistan. Res. Soc. Administrative Pharm., Vol. 13. 10.1016/j.sapharm.2017.07.010.
    CrossRef  |  
  10. Hashmi, F.K., M.A. Hassali, A. Khalid, F. Saleem, H. Aljadhey, Zaheer ud Din Babar and M. Bashaar, 2017. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. BMC Health Ser. Res., Vol. 17. 10.1186/s12913-017-2442-6.
    CrossRef  |  
  11. Hasan, S.S., K. Thiruchelvam, C.S. Kow, M.U. Ghori and Zaheer-Ud-Din Babar, 2017. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities. Expert Rev. Pharm. Outcomes Res., 17: 431-439.
    CrossRef  |  Direct Link  |  
  12. Gammie, T., S. Vogler and Zaheer-Ud-Din Babar, 2017. Economic evaluation of hospital and community pharmacy services. Ann. Pharm., 51: 54-65.
    CrossRef  |  Direct Link  |  
  13. Bashaar, M., M.A. Hassali, F. Saleem, A.A. ALrasheedy, V. Thawani and Z.U. Babar, 2017. Efficacy of international approaches to medicine price regulation and control: A scoping review. J. Applied Pharm. Sci., 7: 227-241.
    Direct Link  |  
  14. Bain, A., L. Nettleship, S. Kavanagh and Z.U. Babar, 2017. Evaluating insulin information provided on discharge summaries in a secondary care hospital in the United Kingdom. J. Pharm. Policy Pract., Vol. 10. 10.1186/s40545-017-0113-y.
    CrossRef  |  
  15. Babar, Z.U.D., R. Kousar, G. Murtaza, S. Azhar, S.A. Khan and L. Curley, 2017. Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature. Res. Soc. Administrative Pharm. 10.1016/j.sapharm.2017.06.008.
    CrossRef  |  
  16. Aziz, M.M., Y. Fang, Z.U. Babar and M. Usman, 2017. Hospital pharmacy services in Pakistan. Eur. J. Hosp. Pharm., 24: 253-253.
    CrossRef  |  Direct Link  |  
  17. Atif, M., S. Scahill, M. Azeem, M.R. Sarwar and Z.U. Babar, 2017. Drug utilization patterns in the global context: A systematic review. Health Policy Technol., 6: 457-470.
    CrossRef  |  Direct Link  |  
  18. Abdel Rida, N., M. Ibrahim, M. Izham, Zaheer-Ud-Din Babar and Y. Owusu, 2017. A systematic review of pharmaceutical pricing policies in developing countries. J. Pharm. Health Ser. Res., 8: 213-226.
    CrossRef  |  Direct Link  |  
  19. Vogler, S., N. Zimmermann, A. Ferrario, V.J. Wirtz and K. de Joncheere et al., 2016. Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. J. Pharm. Policy Pract., Vol. 9. 10.1186/s40545-016-0056-8.
    CrossRef  |  
  20. Vogler, S., A. Vitry and Zaheer-Ud-Din Babar, 2016. Cancer drugs in 16 European countries, Australia and New Zealand: A cross-country price comparison study. Lancet Oncol., 17: 39-47.
    CrossRef  |  Direct Link  |  
  21. Shroff, Z., M. Bigdeli, Zaheer-Ud-Din Babar, A. Wagner, A. Ghaffar and D.H. Peters, 2016. Using health markets to improve access to medicines: Three case studies. J. Pharm. Policy Pract., Vol. 9. 10.1186/s40545-016-0067-5.
    CrossRef  |  
  22. Fisher, D., P. Wick and Zaheer-Ud-Din Babar, 2016. Medicines and the future of health. BMC Med., Vol. 14. 10.1186/s12916-016-0717-0.
    CrossRef  |  
  23. Atif, M., A. Bashir, Q. Saleem, R. Hussain, S. Scahill and Z.U. Babar, 2016. Health-related quality of life and depression among medical sales representatives in Pakistan. SpringerPlus, Vol. 5. 10.1186/s40064-016-2716-1.
    CrossRef  |  
  24. Almarsdottir, A.B. and Zaheer-Ud-Din Babar, 2016. Future methods in pharmacy practice research. Int. J. Clin. Pharm., 38: 724-730.
    CrossRef  |  Direct Link  |  
  25. Zaheer-Ud-Din Babar, C. Lessing, J. Stewart and J. Sheridan, 2015. Evaluating general practitioners' opinions on issues concerning access to medicines in New Zealand. J. Pharm. Health Ser. Res., 6: 145-154.
    CrossRef  |  Direct Link  |  
  26. Wahlster, P., S. Scahill, C.Y. Lu and Zaheer-Ud-Din Babar, 2015. Barriers to access and use of high cost medicines: A review. Health Policy Technol., 4: 191-214.
    CrossRef  |  Direct Link  |  
  27. Vogler, S., K. Kilpatrick and Zaheer-Ud-Din Babar, 2015. Analysis of medicine prices between NZ and 16 european countries. Value Health: J. Int. Soc. Pharm. Outcomes Res., 18: 484-492.
    CrossRef  |  Direct Link  |  
  28. Ragupathy, R. and Zaheer-Ud-Din Babar, 2015. Uptake of new medicines: The Pharmaceutical Management Agency of New Zealand (PHARMAC) in the international context. New Zealand Med. J., 128: 81-83.
    Direct Link  |  
  29. Nikfar, S., Zaheer-Ud-Din Babar, R. Dinarvand, A. Kebriaeezadeh and M. Abdollahi, 2015. Consistent defined threshold and equity in health. DARU J. Pharm. Sci., Vol. 23. 10.1186/s40199-015-0097-6.
    CrossRef  |  
  30. Lu, C.Y., C. Lupton, S. Rakowsky, Z.U. Babar, D. Ross-Degnan and A.K. Wagner, 2015. Patient access schemes in Asia-pacific markets: Current experience and future potential. J. Pharm. Policy Pract., Vol. 8. 10.1186/s40545-014-0019-x.
    CrossRef  |  
  31. Jamshed, S.Q., M.I.M. Ibrahim, M.A. Hassali, A.K. Sharrad, A.A. Shafie and Zaheer-Ud-Din Babar, 2015. Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: A quantitative insight. Adv. Med. Educ. Pract., 6: 359-366.
    CrossRef  |  Direct Link  |  
  32. Gammie, T., C.Y. Lu and Zaheer-Ud-Din Babar, 2015. Access to orphan drugs: A comprehensive review of legislations, regulations and policies in 35 countries. PloS One, Vol. 10. 10.1371/journal.pone.0140002.
    CrossRef  |  
  33. Bigdeli, M., R. Laing, G. Tomson and Zaheer-Ud-Din Babar, 2015. Medicines and universal health coverage: Challenges and opportunities. J. Pharm. Policy Pract., Vol. 8. 10.1186/s40545-015-0028-4.
    CrossRef  |  
  34. Atif, M., S.A.S. Sulaiman, A.A. Shafie and Zaheer-Ud-Din Babar, 2015. Duration of treatment in pulmonary tuberculosis: Are international guidelines on the management of tuberculosis missing something? Public Health, 129: 777-782.
    CrossRef  |  Direct Link  |  
  35. Zaheer-Ud-Din Babar and A. Vitry, 2014. Differences in Australian and new Zealand medicines funding policies. Aust. Prescriber, 37: 150-151.
    CrossRef  |  Direct Link  |  
  36. Wahlster, P., S.L. Scahill, S. Garg and Z. Babar, 2014. Identifying stakeholder opinion regarding access to Cent. Eur. J.Med., 9: 513-527.
    CrossRef  |  Direct Link  |  
  37. Ragupathy, R., Z.U. Babar, W. Mirza, M. Daiya, H. Chandra, A. Yousif and M. Girn, 2014. New Zealand consumers' perceptions of private insurance for pharmaceuticals. SpringerPlus, Vol. 3. 10.1186/2193-1801-3-587.
    CrossRef  |  
  38. Cometto, G., Z.U. Babar, A. Brown, L. Hedman and J. Campbell, 2014. Health supply chain personnel: an integral part of the health workforce. J. Pharm. Pract. Policy, 7: 2-3.
    CrossRef  |  Direct Link  |  
  39. Brown, A., M. Atif, E. Hesselberg, P. Steele, C. Wright and Z.U. Babar 2014. Human resources, health supply chains and access to essential medicines. J.Pharm. Policy Pract., 12: 1-2.
    CrossRef  |  Direct Link  |  
  40. Babar, Z.U.D,and M. Atif, 2014. Differential pricing of pharmaceuticals: A bibliometric review of the literature J.Pharm.Health Serv.Res., 5: 149-156.
    CrossRef  |  Direct Link  |  
  41. Babar, Z.U.D, and S.L. Scahill, 2014. Barriers to effective pharmacy practice in low and high income countries. Integr.Pharm.Res.Pract., 3: 25-27.
    Direct Link  |  
  42. Babar, Z.U.D, S.W. Kan and S. L. Scahill, 2014. Interventions promoting the use of generic medicines: A narrative review of the literature. Health Policy, 14: 285-296.
    CrossRef  |  Direct Link  |  
  43. Babar, Z.U., A. Gray, A. Kiani, S. Vogler, P. Ballantyne and S. Scahill, 2014. The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change. J.Pharm. Policy Pract., vol.7. http://www.joppp.org/content/pdf/2052-3211-7-8.pdf.
  44. Atif, M., S.A.S. Sulaiman, A.A. Shafie, I. Ali, M. Asif and Z.U. Babar, 2014. Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia. BMC Infecti. Dis., Vol. 14. 10.1186/1471-2334-14-399.
    CrossRef  |  Direct Link  |  
  45. Atif, M., S.A.S. Sulaiman, A.A. Shafie, M. Asif, M.K. Sarfraz, H.C. Low and Z.U. Babar, 2014. Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study. Health Qual Life Outcomes, vol.19. 10.1186/1477-7525-12-19 http://www.hqlo.com/content/12/1/19.
    CrossRef  |  
  46. Atif, M., S.A.S. Sulaiman, A.A. Shafie, I. Ali, M. Asif and Z.U. Babar, 2014. Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia. BMC Health Serv. Res.,Vol. 14. 10.1186/1472-6963-14-353.
    CrossRef  |  
  47. Lockhart, M.M., Z.U. Babar, C. Carswel and S. Garg, 2013. New Zealand's Drug Development Industry Int. J. Environ. Res. Public Health.., 10: 4339-4351.
    CrossRef  |  Direct Link  |  
  48. Babar, Z.U.D., S.L. Scahill, S. Garg and M. Akhlaq, 2013. A bibliometric review of pharmacy education literature in the context of low- to middle-income countries Curr. Pharm. Teach. Learn., 5: 218-232.
    CrossRef  |  Direct Link  |  
  49. Babar, Z.U., C. Lessing, C. Mace and K. Bissell, 2013. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics, 31: 1063-1082.
    CrossRef  |  Direct Link  |  
  50. Babar, Z., S.L. Scahill, K. Pengelly, J. Shaw and S. Garg, 2013. Migrant health in New Zealand: exploring issues concerning medicines access and usecess and use'. J.Pharm.Health Serv.Res., 4: 41-749.
    CrossRef  |  Direct Link  |  
  51. Scahill, S., C. Vaughan and Z. Babar, 2012. Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies Southern Med Review 5: 1-2.
    Direct Link  |  
  52. Jamshed, S.Q., M.I.zham, M. Ibrahim, M.A. Hassali and I. Masood et al., 2012. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. South. Med. Rev., 5: 22-30.
  53. Hussain, A., M. Ibrahim and Z.U. Baber, 2012. Compliance with legal requirements at community pharmacies: a cross sectional study from Pakistan. Int. J. Pharm. Pract., 20: 183-190.
    CrossRef  |  Direct Link  |  
  54. Hussain, A., M. Ibrahim and Z.U. Baber, 2012. Using the potential of community pharmacies to promote rational drug use in Pakistan: An opportunity exists or lost? J. Pak. Med. Assoc., 62: 1217-1222.
    Direct Link  |  
  55. Hassali, M.A., A.A. Shafie, Z.U.D. Babar and T.M. Khan, 2012. A study comparing the retail drug prices between Northern Malaysia and Australia. J. Pharm. Health Serv. Res., 3: 103-107.
    CrossRef  |  Direct Link  |  
  56. Babar, Z., P. Grove, P. RachaeL, L. Bye and J. Sheridan, 2012. A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand. BMJ Open, Vol.28. 10.1136/bmjopen-2011-000518 .
    CrossRef  |  Direct Link  |  
  57. Babar, Z., C. Vaughan and S.L. Scahill., Babar, Z., C. Vaughan and S.L. Scahill., 2012. Pharmacy practice: Is the gap between the North and South widening? South. Med. Rev., 5: 1-2.
    Direct Link  |  
  58. Lockhart, M.M., Z.U. Babar and S. Garg, 2011. Drug development in NZ: can a country be a cluster? Drug Dev. Res. 72: 1-8.
    CrossRef  |  Direct Link  |  
  59. Lockhart, M.M., Z.U. Babar, C. Carswel and S. Garg, 2011. Drug development and research in New Zealand: policies affecting the industry. Drug Dev. Res., 73: 1-10.
    CrossRef  |  Direct Link  |  
  60. Jamshed, S.Q., M.I. Ibrahim, A.A. Shafie, M.A. Hassali and Z. Babar, 2011. Generic medicines in Pakistan: A viable cost-effective option for consumers. Eur. J. Clin. Pharm., 67: 969-970.
    PubMed  |  Direct Link  |  
  61. Jamshed, S.Q., M.A. Hassali, M.I. Ibrahim and Z. Babar, 2011. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: A qualitative study. J. Pak. Med. Assoc., 61: 80-83.
    Direct Link  |  
  62. Babar, Z.U.D., S. Jamshed, S.W. Yeong and M.I.M. Ibrahim, 2011. Examination of students' interest in a public health pharmacy course in Malaysia. Curr. Pharm. Teach. Learn., 3: 199-207.
    CrossRef  |  Direct Link  |  
  63. Babar, Z., P. Grover, J. Stewart, M. Hogg, L. Short, H.G. Seo and A. Rew, 2011. Evaluating pharmacists'views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm. 7: 294-305.
    CrossRef  |  Direct Link  |  
  64. Babar, Z., M.I.M. Ibrahim and M.A.A. Hassali, 2011. Pharmaceutical industry, innovation and challenges for public health: case studies from Malaysia and Pakistan. J. Pharm. Health Serv. Res., 2: 193-204.
    Direct Link  |  
  65. Lockhart, M.M., Z. Babar and S. Garg, 2010. New Zealand's drug development industry-strengths and opportunities. N. Z. Med. J., Vol. 123. .
    Direct Link  |  
  66. Lockhart, M., Z.U. Babar and S. Garg, 2010. Evaluation of policies to support drug development in New Zealand. Health Policy. 96: 108-117.
    CrossRef  |  Direct Link  |  
  67. Jamshed, S.Q., M.A. Hassali, M.I. Ibrahim, A.A. Shafie and Z. Babar, 2010. Knowledge, perception and attitude of community pharmacists towards generic medicines in Karachi, Pakistan: A qualitative insight. Trop. J. Pharma. Res., 9: 409-415.
    Direct Link  |  
  68. Hasan, S.S., M.B. Bahari, Z.U. Babar and V. Ganesan, 2010. Antiepileptic drug utilisation and seizure outcome among paediatric patients in a Malaysian public hospital. Singapore Med. J., 51: 21-27.
    Direct Link  |  
  69. Babar, Z., J. Stewart, S. Reddy, W. Alzaher and P. Vareed, 2010. An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm. World Sci., 32: 440-448.
    CrossRef  |  Direct Link  |  
  70. Babar, Z. and S.L. Scahill, 2010. Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries? South. Med. Rev., 3: 1-1.
    Direct Link  |  
  71. Babar, Z. and S. Scahill, 2010. Is there a role for pharmacoeconomics in developing countries? PharmacoEconomics, 28: 1069-1074.
    CrossRef  |  Direct Link  |  
  72. Babar, Z. and N.R.M. Zaini, 2010. Self-medication in Malaysia: a case of midazolam poisoning in a tertiary care hospital. Int. J. Pharm. Pract., 14: 159-159.
    CrossRef  |  Direct Link  |  
  73. Scahill, S., J. Harrison, P. Carswell and Z. Babar, 2009. Organisational culture: an important concept for pharmacy practice research. Pharm. World Sci., 31: 517-521.
    CrossRef  |  Direct Link  |  
  74. Jamshed, S.Q., Z.U.D. Babar and I. Masood, 2009. PharmD in Pakistan: A Tag or Degree? Am. J. Pharm. Edu.,. .
    Direct Link  |  
  75. Jamshed, S.Q., Z. Babar, M.I. Ibrahim and M.A. Hassali, 2009. Generic medicines as a way to improve access and affordability of medicines: A proposed framework for Pakistan. J. Clin. Diagn. Res., 3: 1596-1600.
    Direct Link  |  
  76. Babar, Z.D. and M.I.M. Izham, 2009. Effect of privatization of the drug distribution system on drug prices in Malaysia. Public Health, 123: 523-533.
    CrossRef  |  Direct Link  |  
  77. Babar, Z. and T.L. Beswick, 2009. Southern med review: A new forum to publish "Local pharmaceutical policy in a global context". Pharm. World Sci., 31: 143-144.
    CrossRef  |  Direct Link  |  
  78. Babar, Z.U. and S. Jamshed, 2008. Social pharmacy strengthening clinical pharmacy: Why pharmaceutical policy research is needed in Pakistan?. Pharm. World Sci., 30: 617-619.
    CrossRef  |  PubMed  |  
  79. Babar, Z. and A. Awaisu, 2008. Evaluating community pharmacists' perceptions and practices on generic medicines: A pilot study from Peninsular Malaysia. J. Generic Med., 5: 315-330.
    CrossRef  |  Direct Link  |  
  80. Jamshed, S., Z. Babar and I. Masood, 2007. The PharmD degree in developing countries. Am. J. Pharm.Educ., 5: 315-330.
    CrossRef  |  Direct Link  |  
  81. Babar, Z., N.I. Bukhari, W. Sarwar, B. Efendie, R. Pereira and M.H.N. Mohamed, 2007. A preliminary study on the effect of pharmacist counseling on awareness of and willingness to quit smoking in Malaysian population. Pharm. World Sci., 29: 101-103.
    CrossRef  |  Direct Link  |  
  82. Babar, Z., 2006. Pakistan's national university of pharmaceutical sciences. Am. J. Pharm.Educ., 2006: 123-123.
    Direct Link  |  
  83. Babar, Z. and N.R.M. Zaini, 2006. Harm reduction program and methadone poisoning: Implications for pediatric public health in Malaysia. J. Pharm. Pract., 19: 280-281.
    CrossRef  |  Direct Link  |  
  84. Babar, Z., M.I.M. Ibrahim and M.I. Bukhari, 2005. Medicine utilisation and pricing in Malaysia: The findings of a household survey. J. Generic Med., 3: 47-61.
    CrossRef  |  Direct Link  |